The effect of ascorbic acid on neutrophil functions was investigated.
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-j · ι · « · -j · L-gulonolactone oxidase, L-gulono-y-lactoneioxygen 2-oxi-ascorbic acid with its excellent antioxidative properdoreductase (EC 1. smoke-activated phagocytes (4). Furthermore, an-other report has described ascorbic acid as the most effective antioxidant in human blood plasma in relation to lipid peroxidation (5) , and the authors suggested that ascorbic acid should prove very helpful in the treatment and prevention of diseases and degenerative processes caused by oxidative stress.
Due to an evolutionary defect of the L-gulonolactone oxidase gene, which arose about 60 million years ago, man and some other species are unable to biosynthesize ascorbic acid. It has been calculated that the hypothetical endogenous synthesis capacity of a 70 kg person increases up to 15 g/day under stress, representing the quantity needed for the array of different protective and host defence functions, but which is never be attained by enteral intake (6) . Thus, in extreme oxidative stress situations the infusion of increased amounts of ascorbic acid seems to be necessary and advisable.
Therefore, to substantiate this idea experimentally and to obtain data on the potentially beneficial use of ascorbic acid in organ failure diseases like the adult respiratory distress syndrome (ARDS), we investigated the effect of ascorbic acid on the oxygen radical formation of activated neutrophils and the hypoxanthine/xanthine oxidase system. Furthermore, the influence of ascorbic acid on pathophysiologically important functions of neutrophils, like the lysosomal enzyme release and adherence, was also monitored. Serva, Heidelberg, Germany: latex, Unisphere latex 22, 0.777 μηι diameter, 10%.
Materials and Methods
Riedel-de Haen, Seelze-Hannover, Germany: hypoxanthine.
Chemiluminescence of neutrophils Neutrophils were isolated from citrated blood as previously described (7). Briefly, for the chemiluminescence response the chemiluminescence vials contained the following solutions ( Neutrophils were counted in a Neubauer haemocytometer after staining with Turk's solution.
Replicates and blanks were started simultaneously in a six channel biolurnat LB 9505 (Berthold, Wildbad, Germany), the photon emission was recorded continuously for 60 minutes, the peak maximum values of the blanks were subtracted from the stimulation values and the photon emission was referred to 25 000 cells (chemiluminescence measurement of isolated neutrophils) and to 200 000 cells (chemiluminescence measurement of citrated blood), respectively.
Enzyme release from neutrophils
The enzyme release was measured as follows. Isolated neutrophils were suspended in Minimal Essential Medium at about 4 · 10 9 /1; the reaction mixtures contained: 520 μΐ (520 μΐ) neutrophil suspension, Ο μΐ (20 μΐ) Minimal Essential Medium, 20 μΐ (20 μΐ) pool plasma, 10 μΐ (10 μΐ) ascorbic acid (final concentration 0 -6 mmol/1), and 20 μΐ (Ομί) stimulant (final concentration as described in the section 'Chemiluminescence of neutrophils'). Immediately after starting by the addition of the stimulant, a 100 μΐ aliquot of the reaction mixture was removed and added to 100 μΐ digitonin/Nonidet P40 to lyse the neutrophils for the determination of the total content of elastase 1 ) and -N-acetylglucosaminidase 1 ) (7). After 45 minutes at 37 °C the remaining reaction mixture was centrifuged at 12000g and room temperature for 1 minute. The supernatant was removed and analysed for -N-acetylglucosaminidase spectrofluorimetrically (7) and for elastase by the IMAC test. The percentage of enzyme released was calculated.
Nylon fibre adherence and chemiluminescence of neutrophils For the determination of the nylon fibre adherence and adherence-induced and lucigenin-enhanced chemiluminescence response a modification of the previously described test procedure (8) was used: replicates of 100 μΐ (100 μΐ) citrated blood, 450 μΐ (450 μΐ) Minimal Essential Medium, 10 μΐ (10 μΐ) lucigenin (final concentration 0.23 mmol/1), 10 μΐ (ΙΟμΙ) ascorbic acid (final concentration 0 -6 mmol/1) were incubated for 30 minutes at 37 °C with (A) and without (B) 5 mg of nylon fibre. The photon emission was recorded during incubation. Then the nylon fibre was removed, neutrophils (PMNL) were counted in A and Β using a haemocytometer after staining with Turk's solution, the adherence was calculated by the formula Adherence = PMNL/IB -PMNL/U PMNL/l b (9) and the photon emission (peak maximum) was referred to only adhered cells after subtract!ve correction for the blank.
Chemiluminescence of the hypoxanthine/xanthine oxidase system
To 470 μΐ phosphate buffer (100 mmol/1, pH 7.4) with ethylenediaminetetraacetate (1 mmol/1) and luminol (0.23 mmol/1) were added 10 μΐ hypoxanthine (final concentration 0.2 mmol/1), 10 μΐ ascorbic acid (final concentration 0-1 mmol/1) and 10 μΐ xanthine oxidase (final concentration 0.68 U/l). The photon emission was recorded for 1 minute, and the peak maximum values were determined for each ascorbic acid concentration.
Statistics
The data are expressed as mean ± SEM. Statistical comparisons were performed by Student's t-test for paired data and Wilcoxon's matched pairs signed rank test, respectively. The null hypothesis was rejected for p < 0.05. There was no dose-dependent inhibition of the -Nacetylglucosaminidase ( fig. 2 ). and elastase ( fig. 3 ) release from isolated neutrophils after stimulation with N-formyl-L-methionyl-L-leucyl-L-phenylalanine, latex, lipopolysaccharide, zymosan and 4 -phorbol 12 -myristate 13a-acetate. On the contrary, a slight dose-dependent increase of -N-acetylglucosaminidase was observed after stimulation with zymosan or 4 -phorbol 12 -myristate 13oc-acetate ( fig. 2 ) and of elastase after stimulation with 4 -phorbol 12 -myristate 13oc-acetate ( fig. 3 ).
Results

Figure
The chemiluminescence response of blood was inhibited dose-dependently by ascorbic acid after stimulation with 4 -phorbol 12 -myristate 13a-acetate ( fig.  4) or zymosan (fig. 5 ). During adherence of neutrophils to nylon fibre, ascorbic acid reduced the Chemiluminescence response in a dose-dependent manner, whereas there was no concomitant alteration of the adherence ( fig. 6 ).
Hypoxanthine/xanthine oxidase-generated oxygen radicals showed photon emission curves which were totally suppressed by ascorbic acid. The dose-dependency demonstrated a complete radical scavenging at ascorbic acid concentrations greater than 100 μιηοΐ/ΐ (fig-7 ).
Discussion
Studies by many laboratories have shown a protective effect of different antioxidants against ischemia/reperfusion injury and organ failure. In this report the dose-dependent effect of ascorbic acid has been shown to scavenge oxygen radicals produced by both systems involved in such tissue damage processes:
(i) the activated neutrophil, and
(ii) the hypoxanthine/xanthine oxidase system of e. g. endothelial cells.
The oxygen radical production of the latter system was completely inhibited by small concentrations of ascorbic acid, whereas the incomplete scavenging of respiratory burst-generated oxygen radicals of neutrophils varied in dependence on the stimulus, and higher doses of ascorbic acid were required. This may be a result of the intracellularly produced portion of oxygen radicals which is normally inaccessible for the extracellular ascorbic acid. But one could conceivably increase the intracellular ascorbic acid concentration by insulin, since ascorbic acid/dehydroascorbic acid and glucose seem to use an identical transport system in human neutrophils (10) . Concerning further neutrophil functions, our data demonstrated that the adherence of neutrophils to nylon fibre was not influenced, even by high concentrations of ascorbic acid that produced a nearly complete reduction of the simultaneously observed oxygen radical production. Also the release of lysosomal enzymes was generally unaffected by ascorbic acid, but there was a slight dose-dependent increase of the ß-N-acetylglucosaminidase release when zymosan or 4ß-phorbol 12ß-myristate 12oc-acetate was used for activation, and of the elastase release when 4ß-phorbol 12ß-myristate 13 -acetate was used for activation. We cannot explain this observation.
In view of its excellent antioxidative properties which are highly important for several biochemical pathways (6, 11) and its non-toxic character, ascorbic acid should primarily be recommended as a supplement in animal experiments and clinical studies in patients with trauma, shock and sepsis, i. e. it should be used in the same as other antioxidants like N-acetylcysteine (12) . Furthermore, ascorbic acid can also be recommended for trials to prevent or to reduce reperfusion injuries.
In preliminary experiments we found that sheep tolerated high doses of ascorbic acid intravenously (1 g/kg b. w. as a bolus injection followed by a continuous infusion of 0.2 g/kg · h for 5 hours produced a 50 fold increase of the normal plasma concentration). Experiments are currently being performed in our laboratory on the use of ascorbic acid to prevent the endotoxin-induced pulmonary dysfunction in the sheep model according to Staub et al. (13) .
